Development Level

Tchem 5 | 1,890
Tbio 4 | 10,625

IMPC Term

abnormal coat/hair pigmentatio... 1 | 54
abnormal eye morphology 1 | 38
abnormal humerus morphology 1 | 11
abnormal incisor color 1 | 2
abnormal lens morphology 1 | 73
abnormal response to tactile s... 1 | 16
abnormal tibia morphology 1 | 14
abnormal tooth morphology 1 | 24
cataract 1 | 26
decreased body length 1 | 108
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating chloride... 1 | 32
decreased circulating triglyce... 1 | 83
decreased heart weight 1 | 44
decreased lean body mass 1 | 195
decreased mean corpuscular hem... 1 | 19
increased circulating chloride... 1 | 43

Disease

Cancer 8 | 2,346
ovarian cancer 8 | 8,484
lung cancer 6 | 4,466
astrocytoma 5 | 1,493
glioblastoma 5 | 5,572
medulloblastoma, large-cell 5 | 6,234
psoriasis 5 | 6,685
Breast cancer 4 | 3,094
Colonic Neoplasms 4 | 126
Lung Neoplasms 4 | 171
Multiple myeloma 4 | 1,327
Stomach Neoplasms 4 | 282
atypical teratoid / rhabdoid tumor 4 | 4,369
group 4 medulloblastoma 4 | 1,875
oligodendroglioma 4 | 2,849
osteosarcoma 4 | 7,933
pancreatic cancer 4 | 2,300
pancreatic carcinoma 4 | 567
pediatric high grade glioma 4 | 2,712
pilocytic astrocytoma 4 | 3,086
pituitary cancer 4 | 1,972
primary pancreatic ductal adenocarcinoma 4 | 1,271
subependymal giant cell astrocytoma 4 | 2,287
Cockayne syndrome 3 | 54
Colorectal Neoplasms 3 | 217
Hemangiosarcoma 3 | 18
Liver carcinoma 3 | 217
Mammary Neoplasms 3 | 410
Myocardial Ischemia 3 | 169
Neoplastic Cell Transformation 3 | 81
Vascular disease 3 | 281
Xeroderma pigmentosum 3 | 41
acute myeloid leukemia 3 | 780
adrenocortical carcinoma 3 | 1,427
hepatocellular carcinoma 3 | 532
inflammatory breast cancer 3 | 404
malignant mesothelioma 3 | 3,162
nasopharyngeal carcinoma 3 | 1,056
non-small cell lung cancer 3 | 2,798
primitive neuroectodermal tumor 3 | 3,031
pterygium 3 | 74
Adenoid Cystic Carcinoma 2 | 99
Adenoma 2 | 165
Amyotrophic Lateral Sclerosis 2 | 431
Brain Ischemia 2 | 87
Brain disease 2 | 83
Carcinoma, Transitional Cell 2 | 31
Chronic Lymphocytic Leukemia 2 | 242
Esophageal Neoplasms 2 | 67
Eye disease 2 | 55
Familial adenomatous polyposis 2 | 31
Intestinal Polyps 2 | 5
Intestinal benign neoplasm 2 | 11
Kidney disease 2 | 396
Liver Cirrhosis 2 | 101
Liver disease 2 | 219
Liver neoplasms 2 | 109
Lung disease 2 | 132
Neoplasms, Experimental 2 | 33
Papilloma 2 | 27
Parkinson's disease 2 | 364
Prostatic Neoplasms 2 | 471
Rheumatoid Arthritis 2 | 1,160
Schizophrenia 2 | 501
Squamous cell carcinoma of esophagus 2 | 82
Status Epilepticus 2 | 85
Thyroid Neoplasm 2 | 33
Toxic encephalopathy 2 | 131
Urologic Neoplasms 2 | 7
acute quadriplegic myopathy 2 | 1,157
atypical teratoid/rhabdoid tumor 2 | 1,095
chronic lymphosyte leukemia 2 | 232
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
esophageal adenocarcinoma 2 | 737
gastric cancer 2 | 430
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung carcinoma 2 | 2,844
nephrosclerosis 2 | 329
posterior fossa group A ependymoma 2 | 1,511
sonic hedgehog group medulloblastoma 2 | 1,482
ulcerative colitis 2 | 2,087
Cervix uteri carcinoma in situ 1 | 14
Chronic Obstructive Airway Disease 1 | 47
Endometrial cancer 1 | 25
Epidermodysplasia verruciformis 1 | 21
Gastritis 1 | 44
Gastrointestinal system disease 1 | 50
Hepatoblastoma 1 | 17
Infarction, Middle Cerebral Artery 1 | 25
Lymphoid leukemia 1 | 69
Pancreatitis 1 | 97
Precancerous Conditions 1 | 69
Primary hyperparathyroidism 1 | 4
Skin disease 1 | 65
Squamous cell carcinoma of the head and neck 1 | 24

Tissue

Blood and immune system 9 | 17,995
Cardiovascular System 9 | 17,958
Digestive Tract 9 | 18,473
Endocrine System 9 | 18,512
Female tissues 9 | 18,647
Liver and Pancreas 9 | 18,136
Male tissues 9 | 17,969
Nervous System 9 | 18,561
Respiratory system 9 | 17,484
Skin and soft tissues 9 | 18,115
Urinary Tract 9 | 18,444

Target Family

Non-IDG 5 | 11,971
Transcription Factor 3 | 1,400
Enzyme 1 | 4,146

Grant Application

5R01CA118762-03 9 | 9
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
G1/S-specific cyclin-D1 CCND1 Tchem Non-IDG -3.77851 5447.1 1111
Cullin-4A CUL4A Tchem Non-IDG -1.85960 71.2 245
Cellular tumor antigen p53 TP53 Tchem Transcription Factor -4.67490 51004.8 5255
S-phase kinase-associated protein 1 SKP1 Tbio Enzyme -2.55705 305.8 337
SPARC SPARC Tbio Non-IDG -3.06715 1078.9 468
RING-box protein 2 RNF7 Tbio Non-IDG -1.33581 21.7 113
DNA damage-binding protein 1 DDB1 Tchem Non-IDG -2.30286 191.0 312
Transcription factor AP-1 JUN Tchem Transcription Factor -3.80760 5981.8 2262
Transcription factor jun-B JUNB Tbio Transcription Factor -1.91865 62.8 567